MedTrace Logo

The Effects of Rhus Coriaria L. on Serum Uric Acid Levels

NCT02891031 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2019-04-08

No results posted yet for this study

Summary

The aim of this study is to evaluate the effects of Rhus coriaria L. (Rhus) commonly known as "Somagh" on serum uric acid levels.

Conditions

  • Hyperuricemia

Interventions

DRUG

Rhus (Somagh)

500 mg twice daily after meal for 6 weeks

DRUG

Placebo

500 mg twice daily after meal for 6 weeks

Sponsors & Collaborators

  • Shiraz University of Medical Sciences

    lead OTHER

Principal Investigators

  • Gholamhossein Ranjbar Omrani, MD · Endocrine and Metabolism Research Center, Shiraz University of Medical Sciences

  • Seiyed Mohammad Hosseini-Saadi, MD · Department of Internal Medicine, Shiraz University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2019-11-01
Completion
2019-12-01

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02891031 on ClinicalTrials.gov